Close Menu

NEW YORK – Thermo Fisher Scientific today reported a 4 percent increase in second-quarter revenues, driven by growth across its business segments.

The Waltham, Massachusetts-based company had revenues of $6.32 billion in Q2, up 4 percent from $6.08 billion in the year-ago quarter and just beating the average Wall Street estimate of $6.3 billion. Organic revenues grew 5 percent, acquisitions increased revenue by 1 percent, and currency effects decreased revenue by 2 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers uncovered the HIV virus within a tissue sample collected in 1966, the Atlantic reports.

Nature News reports there are a handful of clinical trials underway to evaluate vaginal microbiome seeding of newborns born via caesarian section.

The Washington Post writes that humans may have contributed to the extinction of cave bears some 20,000 years ago.

In PLOS this week: gene variant may protect against trypanosomiasis, GLIS3 role in type 2 diabetes, and more.